Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group

BACKGROUND: Sequential anthracyclines and taxanes are standard adjuvant chemotherapy for patients with high-risk axillary node-positive breast cancer. We compared a sequential to a concurrent regimen in high-risk node-negative early breast cancer. METHODS: Patients were eligible if they had tumours...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Mavroudis, Dimitrios, Saloustros, Emmanouil, Boukovinas, Ioannis, Papakotoulas, Pavlos, Kakolyris, Stylianos, Ziras, Nikolaos, Christophylakis, Charalampos, Kentepozidis, Nikolaos, Fountzilas, Georgios, Rigas, Georgios, Varthalitis, Ioannis, Kalbakis, Konstantinos, Agelaki, Sofia, Hatzidaki, Dora, Georgoulias, Vasilios
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2017
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584474/
https://ncbi.nlm.nih.gov/pubmed/28641315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.158
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak